Triaza-spirodecanones as DDR1 inhibitors
US10239876B2 · kind B2 · utility
0Cited by
4References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2017 |
| Grant date | Mar 26, 2019 |
| Priority date | — |
| Expiry date | Dec 21, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.